These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32049764)

  • 1. Down syndrome and dementia: advances in the field.
    McGlinchey E; McCallion P; McCarron M
    Curr Opin Psychiatry; 2020 May; 33(3):278-283. PubMed ID: 32049764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible unitary genetic hypothesis for Alzheimer's disease and Down syndrome.
    Schweber M
    Ann N Y Acad Sci; 1985; 450():223-38. PubMed ID: 3160290
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease associated with Down syndrome: a genetic form of dementia.
    Fortea J; Zaman SH; Hartley S; Rafii MS; Head E; Carmona-Iragui M
    Lancet Neurol; 2021 Nov; 20(11):930-942. PubMed ID: 34687637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome.
    Jenkins EC; Ye L; Gu H; Ni SA; Duncan CJ; Velinov M; Pang D; Krinsky-McHale SJ; Zigman WB; Schupf N; Silverman WP
    Neurosci Lett; 2008 Aug; 440(3):340-3. PubMed ID: 18571319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical aging in Down syndrome.
    Zigman WB
    Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical genetics of dementing illness.
    Heston LL
    Neurol Clin; 1986 May; 4(2):439-46. PubMed ID: 3012307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's dementia and Down's syndrome: genetic evidence suggesting an association.
    Heston LL
    Ann N Y Acad Sci; 1982; 396():29-37. PubMed ID: 6217774
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease and maternal age.
    Cohen D; Eisdorfer C; Leverenz J
    J Am Geriatr Soc; 1982 Oct; 30(10):656-9. PubMed ID: 6214576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome.
    Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B
    Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249
    [No Abstract]   [Full Text] [Related]  

  • 12. Alzheimer's disease, Down's syndrome, and aging.
    Ann N Y Acad Sci; 1982; 396():1-199. PubMed ID: 6217771
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosing Alzheimer's dementia in Down syndrome: problems and possible solutions.
    Nieuwenhuis-Mark RE
    Res Dev Disabil; 2009; 30(5):827-38. PubMed ID: 19269132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal telomere shortening and early Alzheimer's disease progression in adults with down syndrome.
    Jenkins EC; Marchi EJ; Velinov MT; Ye L; Krinsky-McHale SJ; Zigman WB; Schupf N; Silverman WP
    Am J Med Genet B Neuropsychiatr Genet; 2017 Dec; 174(8):772-778. PubMed ID: 28856789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive decline and dementia in Down syndrome.
    Hithersay R; Hamburg S; Knight B; Strydom A
    Curr Opin Psychiatry; 2017 Mar; 30(2):102-107. PubMed ID: 28009725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients.
    Shinomoto M; Kasai T; Tatebe H; Kondo M; Ohmichi T; Morimoto M; Chiyonobu T; Terada N; Allsop D; Yokota I; Mizuno T; Tokuda T
    PLoS One; 2019; 14(4):e0211575. PubMed ID: 30951523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.
    Caraci F; Iulita MF; Pentz R; Flores Aguilar L; Orciani C; Barone C; Romano C; Drago F; Cuello AC
    Eur J Pharmacol; 2017 Dec; 817():7-19. PubMed ID: 28987272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down's syndrome and Alzheimer's disease.
    Suchowersky O; Hayden M
    Ann Neurol; 1984 Aug; 16(2):263. PubMed ID: 6236743
    [No Abstract]   [Full Text] [Related]  

  • 19. The link between Down's syndrome and Alzheimer's disease: 2.
    Soliman A; Hawkins D
    Br J Nurs; 1998 Jul 23-Aug 12; 7(14):847-50. PubMed ID: 9849146
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.